In spontaneous intracerebral hematoma patients, prediction of the hematoma expansion risk and mortality risk using radiological and clinical markers and a newly developed scale

Basit Öğe Kaydı
dc.contributor.authorBakar B.
dc.contributor.authorAkkaya S.
dc.contributor.authorSay B.
dc.contributor.authorYuksel U.
dc.contributor.authorAlhan A.
dc.contributor.authorTurğut E.
dc.contributor.authorOgden M.
dc.date.accessioned2021-01-14T18:11:14Z
dc.date.available2021-01-14T18:11:14Z
dc.date.issued2021
dc.departmentKKÜ
dc.description.abstractObjective: In patients with spontaneous intracerebral hematoma (ICH), early-stage hematoma expansion has been associated with poor prognosis in literature. This study aimed to develop predictive parameter(s) as well as a new scale to define hematoma expansion and short-term prognosis in patients with ICH. Methods: In 46 patients with ICH, Glasgow Coma Scale (GCS) scores, non-contrast CT (NCCT) markers (hematoma volume on admission and follow-up, hypodensity, intraventricular hemorrhage, blend and island sign, BAT score), and modified Rankin Scale scores were evaluated for predicting the hematoma expansion risk and mortality risk. Furthermore, a newly developed scale called the ‘HEMRICH scale’ was constituted using the GCS score, hematoma volumes, and some NCCT markers. Results: Roc-Curve and Logistic Regression test results revealed that GCS score, initial hematoma volume value, hypodensity, intraventricular haemorrhage, BAT score, and HEMRICH scale score could be the best markers in predicting hematoma expansion risk whereas GCS score, intraventricular haemorrhage, BAT score, hematoma expansion, and HEMRICH scale score could be the best markers in predicting mortality risk (p = 0.01). Moreover, Factor analysis and Reliability test results showed that HEMRICH scale score could predict both hematoma expansion and mortality risks validly (Kaiser-Meyer-Olkin test value = 0.729) and reliably (Cronbach’s alpha = 0.564). Conclusion: It was concluded that the GCS score, intraventricular haemorrhage, and BAT score could predict both hematoma expansion risk and mortality risk in the early stage in patients with ICH. Furthermore, it was suggested that the newly produced HEMRICH scale could be a valid and reliable scale for predicting both hematoma expansion and mortality risk. © 2021 Informa UK Limited, trading as Taylor & Francis Group.en_US
dc.identifier.doi10.1080/01616412.2020.1870338
dc.identifier.issn0161-6412
dc.identifier.pmid33402048
dc.identifier.scopus2-s2.0-85098847683
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1080/01616412.2020.1870338
dc.identifier.urihttps://hdl.handle.net/20.500.12587/12922
dc.identifier.wosWOS:000605050300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor and Francis Ltd.en_US
dc.relation.ispartofNeurological Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectbat scoreen_US
dc.subjectblend signen_US
dc.subjecthematoma expansionen_US
dc.subjecthypodensityen_US
dc.subjectintraventricular haemorrhageen_US
dc.subjectisland signen_US
dc.subjectmortalityen_US
dc.subjectSpontaneous intracerebral hematomaen_US
dc.titleIn spontaneous intracerebral hematoma patients, prediction of the hematoma expansion risk and mortality risk using radiological and clinical markers and a newly developed scaleen_US
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WOS İndeksli Yayınlar Koleksiyonu